# US 2024/0189345 A1 · Intestinal bacteria reducing agent

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2024/0189345 A1
- Document ID: US20240189345A1
- Status: Published application
- Kind: A1
- Application number: 18/550,844
- Filed: 2022-01-17
- Published: 2024-06-13
- Earliest claimed: 2021-03-24
- Assignees: Osaka University
- Applicants: Osaka University
- Inventors: Hisako KAYAMA; Kiyoshi TAKEDA; Hikaru KOBAYASHI; Yuki KOBAYASHI
- Web page: https://patentgrep.com/patent/US20240189345A1

## CPC

- A23L 33/10: using additives (addition of substantially indigestible substances A23L33/21)
- A61K 33/00: Medicinal preparations containing inorganic active ingredients
- A61K 9/0056: {Mouth soluble or dispersible forms; Suckable, eatable, chewable coherent forms; Forms rapidly disintegrating in the mouth; Lozenges; Lollipops; Bite capsules; Baked products; Baits or other oral forms for animals}
- A61K 9/0095: {Drinks; Beverages; Syrups; Compositions for reconstitution thereof, e.g. powders or tablets to be dispersed in a glass of water; Veterinary drenches (A61K9/0007 takes precedence; eatable gels or foams A61K9/0056; oral mucosa adhesive forms A61K9/006)}
- A61K 9/14: Particulate form, e.g. powders, {Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles (microspheres A61K9/16; microcapsules A61K9/50; nanocapsules, nanoparticles of the matrix type A61K9/51)}
- A61K 9/145: {with organic compounds}
- A61K 9/146: {with organic macromolecular compounds}
- A61K 47/46: Ingredients of undetermined constitution or reaction products thereof, e.g. skin, bone, milk, cotton fibre, eggshell, oxgall or plant extracts
- A61P 31/04: Antibacterial agents
- A61K 9/284: {obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone}
- A61K 9/2866: {Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose}
- A23L: FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF (preservation thereof A23B)
- A61K: PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES (devices or methods specially adapted for bringing pharmaceutical products into particular physical or administering forms A61J3/00; chemical aspects of, or use of materials for deodorisation of air, for disinfection or sterilisation, or for bandages, dressings, absorbent pads or surgical articles A61L; soap compositions C11D)
- A61P: SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS

## Abstract

An intestinal bacteria reducing agent of the present invention is a reducing agent which contains silicon particles or silicon fine particles and reduces the number of bacteria in the intestine. The intestinal bacteria reducing agent can reduce the number of bacteria in the intestine by a new action that cannot be explained by the heretofore known hydrogen generating capability of silicon particles or silicon fine particles, that is, the capability of eliminating hydroxyl radicals.

## Claims

### Claim 1

An intestinal bacteria reducing agent comprising:
silicon particles or silicon fine particles, wherein
the intestinal bacteria reducing agent reduces the number of bacteria in an intestine.

### Claim 2 (depends on 1)

The intestinal bacteria reducing agent according to claim 1, wherein the bacteria include anaerobic bacteria.

### Claim 3 (depends on 1)

The intestinal bacteria reducing agent according to claim 1, wherein the intestinal bacteria reducing agent reduces a ratio of a number of 16S rRNA gene fragments of anaerobic bacteria to a total number of 16S rRNA gene fragments contained in a PCR amplification product obtained by amplifying the 16S rRNA gene using a PCR method.

### Claim 4 (depends on 2)

The intestinal bacteria reducing agent according to claim 2, wherein the anaerobic bacteria are Gram-negative anaerobic bacteria.

### Claim 5 (depends on 2)

The intestinal bacteria reducing agent according to claim 2, wherein the anaerobic bacteria include Bacteroidaceae.

### Claim 6 (depends on 1)

A pharmaceutical product for reducing the number of the bacteria in the intestine, the pharmaceutical product comprising the intestinal bacteria reducing agent according to claim 1.

### Claim 7 (depends on 1)

A food or beverage for reducing the number of the bacteria in the intestine, the food or beverage comprising the intestinal bacteria reducing agent according to claim 1.

### Claim 8 (depends on 3)

The intestinal bacteria reducing agent according to claim 3, wherein the anaerobic bacteria are Gram-negative anaerobic bacteria.

### Claim 9 (depends on 3)

The intestinal bacteria reducing agent according to claim 3, wherein the anaerobic bacteria include Bacteroidaceae.

### Claim 10 (depends on 4)

The intestinal bacteria reducing agent according to claim 4, wherein the anaerobic bacteria include Bacteroidaceae.

### Claim 11 (depends on 2)

A pharmaceutical product for reducing the number of the bacteria in the intestine, the pharmaceutical product comprising the intestinal bacteria reducing agent according to claim 2.

### Claim 12 (depends on 3)

A pharmaceutical product for reducing the number of the bacteria in the intestine, the pharmaceutical product comprising the intestinal bacteria reducing agent according to claim 3.

### Claim 13 (depends on 4)

A pharmaceutical product for reducing the number of the bacteria in the intestine, the pharmaceutical product comprising the intestinal bacteria reducing agent according to claim 4.

### Claim 14 (depends on 5)

A pharmaceutical product for reducing the number of the bacteria in the intestine, the pharmaceutical product comprising the intestinal bacteria reducing agent according to claim 5.

### Claim 15 (depends on 2)

A food or beverage for reducing the number of the bacteria in the intestine, the food or beverage comprising the intestinal bacteria reducing agent according to claim 2.

### Claim 16 (depends on 3)

A food or beverage for reducing the number of the bacteria in the intestine, the food or beverage comprising the intestinal bacteria reducing agent according to claim 3.

### Claim 17 (depends on 4)

A food or beverage for reducing the number of the bacteria in the intestine, the food or beverage comprising the intestinal bacteria reducing agent according to claim 4.

### Claim 18 (depends on 5)

A food or beverage for reducing the number of the bacteria in the intestine, the food or beverage comprising the intestinal bacteria reducing agent according to claim 5.
